• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Hillrom offers $425m in private-placement funding notes

Hillrom offers $425m in private-placement funding notes

September 5, 2019 By Sean Whooley

HillromHillrom (NYSE:HRC) said today that it has launched a planned private offering of more than $400 million in senior unsecured notes.

The Chicago-based medtech company said it intends to use the proceeds from the $425 million offering, along with available cash, to redeem its outstanding 5.75% senior notes due in 2023, including the payment of related fees and expenses.

It’s been a busy summer for the company, which announced its rebranding from Hill-Rom to Hillrom in May, then inked a $170 million deal to sell surgical supplies to Audax in July before agreeing to pay $130 million to acquire Breathe Technologies in August.

The company posted profits of $32.6 million in fiscal Q3, topping the Wall Street consensus. Shares of HRC were up +0.5% at $105.73 in late-morning trading.

Filed Under: Business/Financial News, Featured, Funding Roundup, News Well, Surgical, Wall Street Beat Tagged With: Hillrom

More recent news

  • Paradromics’ first study participant uses BCI for real-time speech
  • Medtronic hires former Recor CEO to run interventional cardiology group
  • Abbott wins FDA approval for Aveir VR Mini ventricular leadless pacemaker
  • Dexcom CFO to expand into COO role
  • Powerful Medical announces FDA De Novo nod for AI ECG and other extra medtech news

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy